Literature DB >> 18687461

The history and challenge of HIV prevention.

Michael H Merson1, Jeffrey O'Malley, David Serwadda, Chantawipa Apisuk.   

Abstract

The HIV/AIDS pandemic has become part of the contemporary global landscape. Few predicted its effect on mortality and morbidity or its devastating social and economic consequences, particularly in sub-Saharan Africa. Successful responses have addressed sensitive social factors surrounding HIV prevention, such as sexual behaviour, drug use, and gender equalities, countered stigma and discrimination, and mobilised affected communities; but such responses have been few and far between. Only in recent years has the international response to HIV prevention gathered momentum, mainly due to the availability of treatment with antiretroviral drugs, the recognition that the pandemic has both development and security implications, and a substantial increase in financial resources brought about by new funders and funding mechanisms. We now require an urgent and revitalised global movement for HIV prevention that supports a combination of behavioural, structural, and biomedical approaches and is based on scientifically derived evidence and the wisdom and ownership of communities.

Entities:  

Mesh:

Year:  2008        PMID: 18687461     DOI: 10.1016/S0140-6736(08)60884-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  77 in total

Review 1.  Toward a comprehensive approach to HIV prevention for people who use drugs.

Authors:  Brandon D L Marshall; Evan Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

2.  Advancing novel HIV prevention intervention research with MSM--meeting report.

Authors:  Cynthia I Grossman; Andrew Forsyth; David W Purcell; Susannah Allison; Carlos Toledo; Christopher M Gordon
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

3.  Performance as a component of HIV/AIDS education: Process and Collaboration for Empowerment and Discussion.

Authors:  Galia Boneh; Devan Jaganath
Journal:  Am J Public Health       Date:  2011-01-13       Impact factor: 9.308

Review 4.  Applicability and generalisability of the results of systematic reviews to public health practice and policy: a systematic review.

Authors:  Nizar Ahmad; Isabelle Boutron; Agnès Dechartres; Pierre Durieux; Philippe Ravaud
Journal:  Trials       Date:  2010-02-26       Impact factor: 2.279

5.  Addressing Health Disparities among Men: Demographic, Behavioral and Clinical Characteristics of Men who have Sex with Men Living in Puerto Rico.

Authors:  Vivian Colón-López; Marievelisse Soto-Salgado; Carlos Rodríguez-Díaz; Erick L Suárez; Cynthia M Pérez
Journal:  Sex Res Social Policy       Date:  2013-09-01

6.  Innovations in sexually transmitted disease partner services.

Authors:  Matthew Hogben; Linda M Niccolai
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

7.  Healthcare Provider Contact and Pre-exposure Prophylaxis in Baltimore Men Who Have Sex With Men.

Authors:  Julia R G Raifman; Colin Flynn; Danielle German
Journal:  Am J Prev Med       Date:  2016-09-20       Impact factor: 5.043

8.  Conceptualizing a Human Right to Prevention in Global HIV/AIDS Policy.

Authors:  Benjamin Mason Meier; Kristen Nichole Brugh; Yasmin Halima
Journal:  Public Health Ethics       Date:  2012-12-05       Impact factor: 1.940

Review 9.  Innovation in sexually transmitted disease and HIV prevention: internet and mobile phone delivery vehicles for global diffusion.

Authors:  Dallas Swendeman; Mary Jane Rotheram-Borus
Journal:  Curr Opin Psychiatry       Date:  2010-03       Impact factor: 4.741

10.  Initial outcomes of provider-initiated routine HIV testing and counseling during outpatient care at a rural Ugandan hospital: risky sexual behavior, partner HIV testing, disclosure, and HIV care seeking.

Authors:  Susan M Kiene; Moses Bateganya; Rhoda Wanyenze; Haruna Lule; Harriet Nantaba; Michael D Stein
Journal:  AIDS Patient Care STDS       Date:  2010-02       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.